OConnell Daniel Joseph
- SEC CIK
- 0001865136
In the past year, 3 open-market sale filings worth $163.2K and no purchases.
Current role at each company
- ABOS Acumen Pharmaceuticals, Inc.Chief Executive Officeras of Jan 23, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $163.2K
- 3 filings
- Net
- −$163.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists OConnell Daniel Joseph as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 (view filing) | Jan 21-22 | 2 days | OConnell Daniel JosephChief Executive Officer | SSale | −12.0K | $1.83 | −$22.0K | −1.3%881.3K after | 2 lots |
| Jan 12, 2026 (view filing) | Jan 8-12 | 4 days | OConnell Daniel JosephChief Executive Officer | SSale | −26.5K | $1.77 | −$46.9K | −4.3%593.5K after | 3 lots |
| Jan 7, 2026 (view filing) | Jan 5-7 | 2 days | OConnell Daniel JosephChief Executive Officer | SSale | −47.5K | $1.99 | −$94.3K | −7.1%620.0K after | 3 lots |
| Jan 23, 2025 (view filing) | Jan 21 | 2 days | OConnell Daniel JosephChief Executive Officer | SSale | −12.6K | $1.59 | −$20.1K | −1.9%667.5K after | 10b5-1 |
| Jan 7, 2025 (view filing) | Jan 3 | 4 days | OConnell Daniel JosephChief Executive Officer | SSale | −47.8K | $1.84 | −$87.9K | −9.5%454.7K after | 10b5-1 |
| Jan 19, 2024 (view filing) | Jan 19 | Same day | OConnell Daniel JosephPresident and CEO | SSale | −15.2K | $3.47 | −$52.7K | −2.9%502.5K after | 10b5-1 |